Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30-Expressing Non-Hodgkin Lymphomas: Results of a Multicenter, Open-Labeled Phase II Trial
Brentuximab Vedotin治疗复发或难治性高CD30表达非霍奇金淋巴瘤的疗效:一项多中心、开放标签II期试验的结果
期刊:Cancer Research and Treatment
影响因子:3.8
doi:10.4143/crt.2019.198
Kim, Seok Jin; Yoon, Dok Hyun; Kim, Jin Seok; Kang, Hye Jin; Lee, Hye Won; Eom, Hyeon-Seok; Hong, Jung Yong; Cho, Junhun; Ko, Young Hyeh; Huh, Jooryung; Yang, Woo-Ick; Park, Weon Seo; Lee, Seung-Sook; Suh, Cheolwon; Kim, Won Seog